Biomarker Data from Phase 1b/2 Investigator-sponsored Trial
LONDON and REDWOOD CITY, Calif., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical stage...
Source: globenewswire.com
📰 Deficiency Cellular Therapy Program News
Deficiency Cellular Therapy Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Deficiency Cellular Therapy Program. Real-time updates on events, politics, business and more.